GSBS Therapeutics & Pharmacology Program,
Monoclonal antibodies (mAbs) continue to reign supreme, although cellular and gene therapies are slowly starting to gather…
Monoclonal antibodies (mAbs) continue to reign supreme, although cellular and gene therapies are slowly starting to gather…
Antibodies continue to dominate biopharmaceutical approvals, but new nucleic acid modalities and cellular therapies are also…